Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

1.50 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact



Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Global Blood Therapeutics.

Target Audience

The intended audience for this activity is hematologists and other health care professionals involved in the treatment of patients with sickle cell disease (SCD).

Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Examine the latest understanding regarding SCD phenotypes as well as implications for treatment and patient outcomes.
  • Assess the latest clinical evidence regarding emerging options for SCD management.
  • Evaluate the benefits and limitations of emerging, potentially curative, treatments for SCD.

Activity Chair

Elliott Vichinsky, MD
Medical Director, Hematology Oncology Division
UCSF Benioff Children's Hospital Oakland
Professor of Pediatrics, University of California at San Francisco
UCSF Benioff Children's Hospital Oakland
Oakland, CA


Kenneth I. Ataga, MD
University of Tennessee Health Science Center
Memphis, TN

Victor R. Gordeuk, MD
Professor of Medicine
University of Illinois at Chicago
Chicago, IL

Mark Walters, MD
UCSF Benioff Children's Hospital Oakland
Oakland, CA


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, January 29, 2019 to January 28, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 out of 4 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationships

Kenneth I. Ataga, MD
Advisory Board: Global Blood Therapeutics, Novartis

Victor R. Gordeuk, MD
Consulting Fee: Global Blood Therapeutics
Contracted Research: Global Blood Therapeutics, Incyte

Elliott Vichinsky, MD
Consulting Fee: Global Blood Therapeutics
Speakers Bureau: Global Blood Therapeutics
Contracted Research: Global Blood Therapeutics

Mark Walters, MD
Consulting Fee: Bioverativ, Bluebird Bio, Editas, Sangamo Therapeutics, TruCode
Medical Director: AllCells, ViaCord Processing Lab

Reviewer reports the following relationship(s)

Ronald A. Codario MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at